NKILA and glioma: As shown in Fig. S3c, the results of HUVEC (human umbilical vein endothelial cell) tube formation assays showed that when Bevacizumab blocked the biological function of VEGFA, glioma cells overexpressing NKILA could not improve the angiogenic ability of endothelial cells as well.